Abstract:Objective To investigate the clinical effect of Montelukast Sodium combined with Salmeterol and Fluticasone Propionate Powders for Inhalation in treatment of asthma.Methods A total of 100 patients with asthma who were admitted to the department of respiratory medicine of our hospital from July 2014 to September 2016 were selected as subjects.They were divided into two groups according to the random number table method,50 cases in eacgh group.The patients in the control group were given conventional treatment with Salmeterol and Fluticasone Propionate Powders for Inhalation,while the patients in the analysis group were added to the treatment of Montelukast Sodium on the basis of the control group.The lung function indicators(lung capacity,exhalation volume,maximum expiratory flow rate),the therapeutic effect and disappearance time of various clinical symptoms of the two groups were compared.Results Before treatment,there was no significant difference in lung function indicators between the two groups (P>0.05).After treatment,the levels of lung function indicators in the analysis group were significantly higher than those in the control group,and the differences were statistically significant(P<0.05).The total effective rate of treatment in the analysis group was 96.00%(48/50),which was significantly higher than 68.00%(34/50)in the control group,and the difference was statistically significant(P<0.05).The disappearance time of cough and asthma in the analysis group were significantly shorter than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Montelukast Sodium combined with Salmeterol and Fluticasone Propionate Powders for Inhalation is more effective in treatment of asthma.It can effectively shorten the disappearance time of symptoms and improve lung function.It has clinical application value.
莫建容; 黄念华; 黎小华. 孟鲁司特钠联合沙美特罗替卡松粉吸入剂治疗哮喘的临床效果[J]. 中国当代医药, 2018, 25(14): 132-134转138.
MO Jian-rong ;HUANG Nian-hua; LI Xiao-hua. Clinical efficacy of Montelukast Sodium combined with Salmeterol and Fluticasone Propionate Powders for Inhalation in treatment of asthma. 中国当代医药, 2018, 25(14): 132-134转138.